Whistal (Whipple + Distal) is a rare parenchyma-preserving technique for select patients with disease in both the pancreatic head and tail, sparing a disease-free middle segment. It may also be used after prior partial pancreatectomy. Surgical resection remains the cornerstone of treatment for pancreatic diseases such as PDAC, RCC metastasis, and multifocal IPMN. Whistal may balance oncologic control with pancreatic function preservation. Though infrequent, it is practiced and reported in literature.
Methods
With IRB approval, a retrospective review of a prospective database (Aug 1999-Mar 2024) identified Whistal cases, categorized as staged Whistal (SW) or concomitant whistal (CW). Perioperative outcomes were assessed via Clavien-Dindo and ISGPS. A PubMed search identified reported middle segment pancreatectomy (Whistal) cases.
Results
Of 2008 resections (Aug 1999-Mar 2024), 5 were Whistals (3 CW, 2 SW) for PDAC (n = 3), RCC (n = 1), IPMN (n = 1), and bile duct stricture (n = 1). Rates for major morbidity, POPF, and DGE were each 40%. Literature review found 26 papers reporting 52 additional Whistal cases.
Conclusion
Whistal is safe for select patients, but wider adoption and long-term data are needed to confirm its efficacy.
SiassiMKleinPHohenbergerW. Organ-preserving surgery for multicentric carcinoma of the pancreas. Eur J Surg Oncol. 1999;25:548-550. doi:10.1053/ejso.1999.0696
2.
MiuraFTakadaTAmanoHYoshidaMToyotaNWadaK. Middle-Segment–Preserving pancreatectomy. J Am Coll Surg. 2007;204:720-722. doi:10.1016/j.jamcollsurg.2007.01.007
3.
LloydFPKangJ. Multifocal papillary-cystic neoplasm of the pancreas. J Natl Med Assoc. 2003;95:1204-1207.
4.
PartelliSBoninsegnaLSalviaRBassiCPederzoliPFalconiM. Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. Am J Surg. 2009;198:e49-e53. doi:10.1016/j.amjsurg.2009.02.017
5.
ChiangK-CHsuJTChenH-Y, et al.Multifocal intraductal papillary mucinous neoplasm of the pancreas-A case report. World J Gastroenterol. 2009;15:628-632. doi:10.3748/wjg.15.628
6.
KitasatoATajimaYKurokiT, et al.Limited pancreatectomy for metastatic pancreatic tumors from renal cell carcinoma. Hepatogastroenterology. 2010;57:354-357.
7.
SpertiCPolizziMLMoroMBeltrameVPedrazzoliS. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection. JOP J Pancreas. 2010;11:258-261. doi:10.6092/1590-8577/3824
8.
OhzatoHYamamotoTFukunagaMImamuraHFurukawaH. Middle-preserving pancreatectomy for multifocal metastatic renal cell carcinoma located in the head, body and tail of the pancreas. A case report. JOP J Pancreas. 2010;11:633-637. doi:10.6092/1590-8577/3413
9.
NodaHKatoTKamiyamaHToyamaNKonishiF. Middle-preserving pancreatectomy for advanced transverse colon cancer invading the duodenun and non-functioning endocrine tumor in the pancreatic tail. Clin J Gastroenterol. 2011;4:24-27. doi:10.1007/s12328-010-0189-2
10.
HoriguchiAIshiharaSItoM, et al.Middle-segment-preserving pancreatectomy for biliary-pancreatic tumors. Hepatogastroenterology. 2011;58:1018-1021.
11.
ChenHWangFLaiECHLauWY. Middle-preserving pancreatectomy for synchronous ampullary carcinoma and solid-pseudopapillary tumor of distal pancreas. Int J Surg Case Rep. 2011;2:267-268. doi:10.1016/j.ijscr.2011.08.007
12.
OtaniTEnamiYTanakaK, et al.Simultaneous pancreaticoduodenectomy and distal pancreatectomy for 2 IPMNs in the head and the tail. Pancreas. 2011;40:165-167. doi:10.1097/MPA.0b013e3181eabb12
13.
ChengKShenBPengCNaLChengD. Middle-preserving pancreatectomy: report of two cases and review of the literature. World J Surg Oncol. 2013;11:106. doi:10.1186/1477-7819-11-106
14.
AryalBKomokataTKadonoJ, et al.Middle-preserving pancreatectomy with reversed pancreaticogastrostomy: report of a case. Surg Today. 2014;44:1584-1587. doi:10.1007/s00595-013-0692-4
15.
NishiMKawasakiHFujiiM, et al.Middle-preserving pancreatectomy for multifocal intraductal papillary mucinous neoplasms of the pancreas: report of a case. Clin J Gastroenterol. 2014;7:251-254. doi:10.1007/s12328-014-0472-8
16.
TakeshiAMitsuhiroIHiromitsuA, et al.Middle segment-preserving pancreatectomy for recurrent metastasis of renal cell carcinoma after pancreatoduodenectomy: a case report. Case Rep Surg. 2014;2014:648678. doi:10.1155/2014/648678
17.
UsuiMKuriyamaNUchidaK, et al.Laparoscopy assisted middle-segment–preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case. Asian J Endosc Surg. 2014;7:271-274. doi:10.1111/ases.12107
18.
LuZYinJWeiJ, et al.Small amounts of tissue preserve pancreatic function: long-term follow-up study of middle-segment preserving pancreatectomy. Medicine (Baltim). 2016;95:e5274. doi:10.1097/MD.0000000000005274
19.
YamadaMSugiuraTOkamuraY, et al.Middle segment-preserving pancreatectomy for metachronous intraductal papillary mucinous neoplasm after pancreatoduodenectomy: a case report. Surg Case Rep. 2017;3:28. doi:10.1186/s40792-017-0306-2
20.
NittaNYamamotoYSugiuraT, et al.Middle segment-preserving pancreatectomy for multifocal pancreatic ductal adenocarcinoma located in the head and tail of the pancreas: a case report. J Surg Case Rep. 2020;2020:rjaa383. doi:10.1093/jscr/rjaa383
IguchiTIsedaNHiroseK, et al.Indocyanine green fluorescence to ensure perfusion in middle segment-preserving pancreatectomy: a case report. Surg Case Rep. 2021;7:262. doi:10.1186/s40792-021-01344-y
23.
MiharaFTakemuraNYoshizakiY, et al.Middle-segment preserving pancreatectomy: a literature review and case report. Langenbecks Arch Surg. 2024;409:177. doi:10.1007/s00423-024-03370-4
24.
MarshallGByrneMWirthKLiaoXLinehanDCWilsonNA. Middle-preserving pancreatectomy for multicentric solid pseudopapillary neoplasm in a 10-Year-Old female. Eur J Pediatr Surg Rep. 2024;12:e58-e62. doi:10.1055/s-0044-1791812
25.
YamaneMIshikawaYYamashitaH, et al.Middle segment preserving pancreatectomy versus total pancreatectomy: a comparative analysis of short- and long-term outcomes. Surg Today. 2025;55:930-940. doi:10.1007/s00595-024-02973-0
26.
FuruyaRTakedaYTakahashiA, et al.Comparative outcomes of parenchyma-sparing repeat pancreatectomy vs completion pancreatectomy: impact on endocrine function and diabetes management. J Gastrointest Surg. 2025;29:102040. doi:10.1016/j.gassur.2025.102040
27.
AsbunHJVan HilstJTsamalaidzeL, et al.Technique and audited outcomes of laparoscopic distal pancreatectomy combining the clockwise approach, progressive stepwise compression technique, and staple line reinforcement. Surg Endosc. 2020;34(1):231-239. doi:10.1007/s00464-019-06757-3
28.
BolligerMKroehnertJ-AMolineusFKandiolerDSchindlMRissP. Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients. Eur Surg. 2018;50:256-261. doi:10.1007/s10353-018-0551-z
29.
DuschNLietzmannABarthelsFNiedergethmannMRückertFWilhelmTJ. International study group of pancreatic surgery definitions for postpancreatectomy complications: applicability at a high-volume center. Scand J Surg. 2017;106:216-223. doi:10.1177/1457496916680944
30.
ZovakMMužina MišićDGlavčićG. Pancreatic surgery: evolution and current tailored approach. Hepatobiliary Surg Nutr. 2014;3:247-258. doi:10.3978/j.issn.2304-3881.2014.09.06
31.
TanisPJvan der GaagNABuschORCvan GulikTMGoumaDJ. Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg. 2009;96:579-592. doi:10.1002/bjs.6606
32.
BarugolaGFalconiMBettiniR, et al.The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP J Pancreas. 2007;8:132-140.
33.
Van den broeckASergeantGEctorsNVan SteenbergenWAertsRTopalB. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol. 2009;35:600-604. doi:10.1016/j.ejso.2008.12.006
34.
SellnerFTykalskyNDe SantisMPontJKlimpfingerM. Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol. 2006;13:75-85. doi:10.1245/ASO.2006.03.064
35.
KassabianASteinJJabbourN, et al.Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology. 2000;56:211-215. doi:10.1016/S0090-4295(00)00639-7
MarchegianiGMino-KenudsonMFerroneCR, et al.Patterns of recurrence after resection of IPMN: who, when,...: annals of surgery n.d.
38.
MiyamotoRInagakiYIkedaNOdaT. Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy. Pancreatology. 2020;20:867-874. doi:10.1016/j.pan.2020.06.018
39.
OkanoKMurakamiYNakagawaN, et al.Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy. Surgery. 2016;159:885-892. doi:10.1016/j.surg.2015.08.046
40.
NakamuraHMurakamiYUemuraK, et al.Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy. J Surg Res. 2011;171:473-478. doi:10.1016/j.jss.2010.03.052
41.
HempelSOehmeFTahirukajE, et al.More is more? Total pancreatectomy for periampullary cancer as an alternative in patients with high-risk pancreatic anastomosis: a propensity score-matched analysis. Ann Surg Oncol. 2021;28:8309-8317. doi:10.1245/s10434-021-10292-8
42.
MiyasakaYOhtsukaTMatsudaR, et al.High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms. Surg Today. 2020;50:832-8340. doi:10.1007/s00595-019-01852-3
43.
AlmondMRobertsKJHodsonJ, et al.Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB. 2015;17:416-421. doi:10.1111/hpb.12365
44.
WuWDodsonRMakaryMA, et al.A contemporary evaluation of the cause of death and long-term quality of life after total pancreatectomy. World J Surg. 2016;40:2513-2518. doi:10.1007/s00268-016-3552-8
45.
FangW-LSuC-HShyrY-M, et al.Functional and morphological changes in pancreatic remnant after pancreaticoduodenectomy. Pancreas. 2007;35:361-365. doi:10.1097/MPA.0b013e3180d0a8d5
46.
SatoNYamaguchiKYokohataK, et al.Long-term morphological changes of remnant pancreas and biliary tree after pancreatoduodenectomy on CT. Int Surg. 1998;83:136-140.
47.
LemaireEO’TooleDSauvanetAHammelPBelghitiJRuszniewskiP. Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg. 2000;87:434-438. doi:10.1046/j.1365-2168.2000.01388.x
48.
YooDHwangSKimK-H, et al.Pancreatic atrophy relative to external versus internal drainage of the pancreatic duct after pylorus-preserving pancreaticoduodenectomy. J Gastrointest Surg. 2014;18:1604-1609. doi:10.1007/s11605-014-2583-4
49.
JungWKimHKwonWJangJ-Y. Atrophy of remnant pancreas after pancreatoduodenectomy: risk factors and effects on quality of life, nutritional status, and pancreatic function. J Hepatobiliary Pancreat Sci. 2022;29:239-2349. doi:10.1002/jhbp.949
